Industrial applicability of enzymatic and whole-cell processes for the utilization of C1 building blocks.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40750581.
- Also identified by DOI 10.1038/s41467-025-60777-3 and PMC identifier 12316909.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chemicals produced through enzymatic reactions play a key role in the transition from a linear petrol-dependent to a circular bioeconomy. One promising approach is the conversion of single carbon (C<sub>1</sub>) molecules by biocatalysts to value-added products. Although progress has been made, current biological methods remain less cost-competitive than established chemical processes. Here, we review how single and multi-enzyme transformations, natural C<sub>1</sub>-trophic microorganisms, and organisms with transplanted synthetic C<sub>1</sub> assimilation pathways can synergize to strengthen the competitiveness of C<sub>1</sub>-based biomanufacturing. To explore the current state-of-the-art and assess the potential of C<sub>1</sub> biomanufacturing, we highlight the aforementioned bio-based methodologies and evaluate their industrial applicability through an overview of granted patents.
Medical subject headings
- Carbon
- Enzymes